Cargando…

Post-marketing safety signals: Challenges in regulatory decisions, communication & impact evaluation in developing countries

Detalles Bibliográficos
Autor principal:	Kshirsagar, Nilima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819025/ https://www.ncbi.nlm.nih.gov/pubmed/29434057 http://dx.doi.org/10.4103/ijmr.IJMR_1070_17

Ejemplares similares

Evaluating Chemical Mixtures in Epidemiological Studies to Inform Regulatory Decisions
por: Savitz, David A., et al.
Publicado: (2023)

Decisions by regulatory agencies: are they evidence-based?
por: Furberg, Curt D
Publicado: (2007)

Vaccine Impact Data Should Support Country Decision Making
por: Nelson, E Anthony S, et al.
Publicado: (2017)

Shifting North American drug markets and challenges for the system of care
por: Krausz, R. Michael, et al.
Publicado: (2021)

The challenge of radiology education in developing countries
por: Ramírez-Arias, JL, et al.
Publicado: (2008)

A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now?
por: Baumgartner, Christian, et al.
Publicado: (2023)

Assessment of the COVID-19 vaccine market landscape in 2021 relative to challenges in low- and middle-income countries
por: Oddleifson, D. August, et al.
Publicado: (2022)

Impact of Regulatory Changes on Innovations in the Medical Device Industry: Comment on "Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We Ready for It? - A Viewpoint Paper"
por: Maresova, Petra
Publicado: (2022)

The Challenges of Regulating Artificial Intelligence in Healthcare: Comment on "Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We Ready for It? - A Viewpoint Paper"
por: McKee, Martin, et al.
Publicado: (2022)

Developing countries and neglected diseases: challenges and perspectives
por: Boutayeb, Abdesslam
Publicado: (2007)

How much safety is actually ‘safe’? Commentary on ‘Safety of the Apollo Onyx delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study’ by Meyers et al
por: Sirakov, Alexander, et al.
Publicado: (2021)

Mitigation of non-communicable diseases in developing countries with community health workers
por: Mishra, Shiva Raj, et al.
Publicado: (2015)

Non‐Communicable Diseases (NCDs) in developing countries: a symposium report
por: Islam, Sheikh Mohammed Shariful, et al.
Publicado: (2014)

First steps to creating high impact theory in marketing
por: Bolton, Ruth N.
Publicado: (2020)

Beyond post-marketing research and MedWatch: Long-term studies of drug risks
por: Resnik, David B
Publicado: (2007)

Clinical Trial Diversity in Oncology: FDA Takes Action with Post–Marketing Requirements or Commitments
por: Kim, Janice, et al.
Publicado: (2022)

Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies
por: Hooimeyer, Ashleigh, et al.
Publicado: (2020)

Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
por: Ncube, Bakani Mark, et al.
Publicado: (2021)

Is sustainable marketing based on virtue ethics the answer to addressing socio-ecological challenges facing humankind?
por: Prothero, Andrea, et al.
Publicado: (2021)

Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report
por: Pai, Sarayu A., et al.
Publicado: (2016)

Military culture and collaborative decision-making in mental healthcare: cultural, communication and policy considerations
por: Treichler, Emily B. H., et al.
Publicado: (2023)

Nonmonotonic Dose–Response Curves Occur in Dose Ranges That Are Relevant to Regulatory Decision-Making
por: Hill, Corinne E., et al.
Publicado: (2018)

Relevance, rigor and impact of scholarly research in marketing, state of the discipline and outlook
por: Varadarajan, Rajan
Publicado: (2020)

The Instrumental Role of Strategic Communication to Counter Industry Marketing Responses to Sugary Drink Taxes: Comment on "Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, 2019"
por: Murukutla, Nandita, et al.
Publicado: (2023)

Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
por: Li, Chunxiao, et al.
Publicado: (2018)

Resurrecting marketing
por: Belk, Russell
Publicado: (2020)

The Challenges of Program Accreditation Decisions in 2021 for the ACGME Review Committee for Surgery
por: Potts, John R., et al.
Publicado: (2021)

MedDRA Labeling Groupings to Improve Safety Communication in Product Labels
por: Große-Michaelis, Ilona, et al.
Publicado: (2022)

Evaluating the consequences of health policy decisions
por: Nimptsch, Ulrike
Publicado: (2020)

Overcoming challenges to dissemination and implementation of research findings in under-resourced countries
por: Derman, Richard J., et al.
Publicado: (2018)

Combatting Substandard and Counterfeit Medicines in the Nigerian Drug Market: How Industrial Pharmacists Can Rise Up to the Challenge
por: Okereke, Melody, et al.
Publicado: (2021)

Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

The Difficult Balance between Ensuring the Right of Nursing Home Residents to Communication and Their Safety
por: Bolcato, Matteo, et al.
Publicado: (2021)

Adequacy of safety data for regulatory approval of pediatric indication through extrapolation algorithm
por: Park, Min Soo
Publicado: (2021)

Harnessing information and communication technologies to leverage scarce resources for cancer education, research and practice in developing countries
por: Andela, Valentine B
Publicado: (2006)

The future of health markets
por: Bennett, Sara, et al.
Publicado: (2014)

Safety of Enteral Nutrition Practices: Overcoming the Contamination Challenges
por: Sinha, Saswati, et al.
Publicado: (2020)

Driving Decisions: Distinguishing Evaluations, Providers and Outcomes
por: Dickerson, Anne, et al.
Publicado: (2018)

Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries
por: Gyawali, Bishal, et al.
Publicado: (2016)

Challenges to peer support in low- and middle-income countries during COVID-19
por: Mpango, Richard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e2ohvo87hu1ut0tv4dins529fc